Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.alpalabs.in | |
Market Cap | 175.50 Cr. | |
Enterprise Value(EV) | 177.06 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 8.55 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 9.76 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.54 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 70.26 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 1.19 | Calculated using Price: 83.41 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 2.10 Cr. | 21,040,600 Shares |
FaceValue | 10 | |
About Alpa Laboratories Ltd. | ||
Alpa Laboratories, incorporated in 1988, is engaged in the business of manufacturing pharmaceutical products. In 1967, the company started its journey as a partnership concern with Purushottam R Patel, M S Chawla and Pravin C Shah as the founding partners. Later on March 18, 1988 the company became a private limited company and a decade later it became a public limited enterprise. |
1 Day |
|
-1.65% |
1 Week |
|
-3.04% |
1 Month |
|
-17.62% |
3 Month |
|
-20.19% |
6 Month |
|
+14.98% |
1 Year |
|
+56.51% |
2 Year |
|
+15.72% |
5 Year |
|
+205.32% |
10 Year |
|
+693.14% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -1.6 | 7.61 | 2.68 | 2.92 | 1.03 | 1.86 | 6.97 | 12.29 | 9.82 | |
Return on Capital Employed (%) | -0.89 | 9.61 | 6.59 | 5.47 | 3.26 | 3.09 | 10.42 | 16.81 | 12.19 | |
Return on Assets (%) | -1.1 | 4.99 | 1.86 | 2.29 | 0.84 | 1.54 | 5.56 | 9.53 | 7.8 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 87 | 93 | 95 | 98 | 98 | 100 | 108 | 122 | 135 | 143 | |
Non Curr. Liab. | 0 | 1 | 0 | 0 | 0 | -1 | 0 | 5 | 3 | 2 | |
Curr. Liab. | 41 | 52 | 30 | 23 | 22 | 21 | 33 | 29 | 30 | 38 | |
Minority Int. | |||||||||||
Equity & Liab. | 128 | 146 | 125 | 121 | 121 | 120 | 140 | 155 | 167 | 184 | |
Non Curr. Assets | 16 | 27 | 20 | 23 | 27 | 25 | 19 | 17 | 18 | 16 | |
Curr. Assets | 113 | 119 | 105 | 98 | 94 | 95 | 121 | 138 | 149 | 168 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 128 | 146 | 125 | 121 | 121 | 120 | 140 | 155 | 167 | 184 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 57 | 54 | 63 | 63 | 78 | 86 | 98 | 112 | 93 | 114 | |
Other Income | 3 | 6 | 5 | 5 | 5 | 3 | 4 | 11 | 9 | 10 | |
Total Income | 61 | 59 | 69 | 68 | 83 | 89 | 102 | 123 | 102 | 125 | |
Total Expenditure | -55 | -47 | -56 | -59 | -77 | -83 | -90 | -102 | -85 | -100 | |
PBIDT | 6 | 12 | 12 | 9 | 6 | 6 | 12 | 21 | 17 | 24 | |
Interest | -2 | -1 | -2 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | -6 | -1 | -3 | -3 | -3 | -3 | -1 | -2 | -1 | -2 | |
Taxation | 1 | -3 | -3 | -2 | -2 | -1 | -4 | -5 | -3 | -4 | |
Exceptional Items | -1 | -2 | 0 | ||||||||
PAT | -1 | 7 | 3 | 3 | 1 | 2 | 7 | 14 | 13 | 18 | |
Minority Interest | |||||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | -1 | 7 | 3 | 3 | 1 | 2 | 7 | 14 | 13 | 18 | |
Adjusted EPS | -1 | 3 | 1 | 1 | 0 | 1 | 3 | 7 | 6 | 9 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 8 | -2 | -22 | 17 | -13 | -1 | 18 | -2 | 10 | 9 | |
Cash Fr. Inv. | -2 | 37 | -8 | -2 | -11 | -15 | -11 | 6 | -16 | 2 | |
Cash Fr. Finan. | 4 | 7 | -6 | -15 | 9 | -5 | -1 | 0 | 5 | -4 | |
Net Change | 10 | 42 | -36 | 0 | -15 | -20 | 5 | 4 | 0 | 7 | |
Cash & Cash Eqvt | 10 | 53 | 17 | 37 | 21 | 1 | 6 | 11 | 2 | 9 |
Tue, 13 Feb 2024
Results For The Quarter Ended December 2023 Results for the Quarter ended December 2023 |
Thu, 01 Feb 2024
Board Meeting Intimation for To Consider The Financial Results For The Quarter Ended On 31St December 2023. ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve to consider the Financial Results for the Quarter ended on 31st December 2023. |
Tue, 02 Jan 2024
Closure of Trading Window Closure of Trading Window |
Thu, 28 Mar 2024 |
High Delivery Percentage |
Making Lower Lows for 3 days |
Close Below Last Week Low |
Close Below Last Month Low |
Making Lower Lows for 2 Days |